Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 16 of 16 for “"RHUEPO"”.
-
A novel transcriptomic based approach to the detection of recombinant human erythropoietin doping
… of recombinant human erythropoietin (rHuEpo) improves endurance performance. Hence rHuEpo is, allegedly, frequently subject to abuse by athletes, although rHuEpo is prohibited by the World Anti-Doping Agency. A transcriptomic-based longitudinal screening approach has the potential to …
-
Pharmacokinetic and Pharmacodynamic Modeling of Recombinant Human Erythropoietin: The Basis for Improvement of Personalized Anemia Management
… bone marrow. Recombinant human erythropoietin (rHuEPO, epoetin alfa) is the first erythropoiesis-stimulating agent (ESA) approved for clinical use in the late 1980s. It has been proven to be effective for the treatment of anemia induced by chronic kidney disease (CKD), chemotherapy, and some …
-
Η επίδραση της ερυθροποιητίνης και της L- καρνιτίνης στην αναιμία των αιμοκαθαιρομένων
… or reduce the recombinant human erythropoietin (rhuEPO) dose needed to achieve a desired hematocrit level. The purpose of present study is to demonstrate whether L- carnitine supplementation to hemodialysed patients treated with rhuEPO could further improve their hematologic status, also leading …
-
Erythropoietin Promotes Hepatic Regeneration After Extended Liver Resection in Rats
… organs. To date no data is available on whether rHuEPO has the ability to stimulate liver regeneration after liver resection. Using a rat model of liver resection we aimed to determine the effect of the administration of human recombinant erythropoietin (rHuEPO) on liver regeneration. Rats were …
-
Η δυνατότητα βελτίωσης του ποσοστού επιβίωσης των δερματικών μοσχευμάτων ολικού πάχους μετά από τροποποίηση του περιβάλλοντος υποδοχής τους με την επίδραση ειδικών παραγόντων
… infused human recombinant erythropoietin (rHuEPO) and tacrolimus(FK506).Material: Five groups of Wistar rats, weighting 220-350gr, each consisting of 6 subjects were included in the study. The study was conducted according to the National Research Council guidelines for the care and use of …
-
Μελέτη της επίδρασης της ερυθροποιητίνης σε χειρουργικούς ασθενείς
… sampling. Comparisons were done between the (rhuEPO) group and the control (placebo) group. Peripheral blood samples and drainage samples were systematically collected at designated time points. Major human lymphocyte population, cytokine expression and metabolic parameters were monitored. The …
-
Η εφαρμογή της υποδόριας χορήγησης ερυθροποιητίνης σε ασθενείς που υποβάλλονται σε συνεχή φορητή περιτοναϊκή κάθαρση
… IN THESE PATIENTS AN INITIAL DOSE OF 50 U/KG RHUEPO WAS SUBCUTANEOUSLY ADMINISTERED, TWICE A WEEK. EXCEPT FOR THE HEMATOLOGICAL EVALUATION, THE PERITONEAL KINETIC PARAMETER MODIFICATIONS AND THE BIOCHEMICAL SERUM VALUES CHANGES WERE ALSO MEASURED, BEFORE AND AFTER THE CORRECTION OF ANEMIA. IN …
-
Influence de l'activité érythropoïétique sur le métabolisme et le monitoring martial: Un rôle pour les indices des érythrocytes matures
… les programmes d’autotransfusion supporté par rHuEPO, la disponibilité du fer peut également limiter l’érythropoïèse. En l’absence de supplémentation martiale, le succès de tels programmes est conditionné par la quantité de fer circulant mobilisable de départ mais ne dépend que peu du fer de …
-
Erythropoietin Signaling in Pancreatic Beta Cells in Homeostasis and in Models of Type 1 and Type 2 Diabetes
… we report that recombinant human erythropoietin (rHuEPO) administration provided protection against diabetes development in the streptozotocin (STZ)-induced and db/db mice, models of type 1 and type 2 diabetes, respectively, through anti-apoptotic, proliferative and angiogenic effects within the …
-
Influence of athletes hyperhydration on sample collection procedure in terms of plasma and urine pharmacokinetics of representative prohibited substances
… prohibited substances, namely, Epoetin beta (rHuEPO) and budesonide (BDS) after a single subcutaneous and oral dose administration, respectively. The presentation of the study results is structured into three Parts (A-C). In the first part, “Part A: Introduction & Study design”, the rational …
-
Η χρήση της ανθρώπινης ανασυνδυασμένης ερυθροποιητίνης στην αντιμετώπιση της αναιμίας της κύησης και της λοχείας
… patients. We recommend administration of s.c. rHuEPO 200 iu/kg, with 200 mg Fe and 5 mg Fillicine for treatment of anaemia in pregnancy and post-partum, under medical care.
-
Μεταβολές της συγκεντρώσεως της ερυθροποιητίνης στα διάφορα στάδια της HIV νόσου
… the correction of anemia with the allowance of rHuEPO and not with the transfusion of blood corpuscles or blood. In addition, adaptability was assumed in 19% of the model's cases, which presented erythropoietin as the depended variable among patients who took medication. It was also proved that …
-
Δείκτες επάρκειας σιδήρου σε ασθενείς με τελικό στάδιο της χρόνιας νεφρικής ανεπάρκειας
… were included. All patients were on stable rHuEPO maintenance dose and had no transfusions or per os/parenteral iron administration for at least 2 months. There were 52 men (53%), their mean age was 65 years and the mean duration of hemodialysis was 62 months. Detailed medical history and …
-
Detection of blood doping in athletes (masking substances and methods)
… and abusing recombinant human erythropoietin (rHuEPO). Continuous monitoring all year round and creating haematological profiles, known as athlete’s haematological or blood passport with cut-off values, are being practiced by some international sport federations to ban athletes from …
-
Κυτταρογενετικός έλεγχος της δράσης της ερυθροποιητίνης σε λεμφοκύτταρα περιφερικού αίματος ανθρώπου in vitro και σε καρκινικά κύτταρα P388 σε πειραματόζωα in vivo
… in the forms of artificial analogues, such as rHuEpo, may offer special advantages to human body, which makes protein usage essential in a wide range of diseases